Advocacy

Advocacy News

ASAM and NJSAM Submit Letters of Support for Legislation to Allow NPs and PAs to Prescribe Buprenorphine for Addiction Treatment

June 29, 2017

Letter of Support for A4910

Letter of Support for S3272

 

ASAM and the New Jersey Society of Addiction Medicine (NJSAM) submitted letters of support with a recommended revision for A4910 and S3272, legislation that would align state law with federal law to allow NPs and PAs to prescribe buprenorphine for addiction treatment.